Skip to main content

Table 2 Perioperative findings and clinical outcomes

From: Predictors of short-term thrombocytopenia after transcatheter aortic valve implantation: a retrospective study at a single Japanese center

 

Total (n = 131)

DPC of ≥ 50% (n = 74)

DPC of < 50% (n = 57)

P-value

Valve type (BEV)

110 (84%)

67 (90.5%)

43 (75.4%)

0.019

Contrast medium volume (mL)

86.7 ± 26.0

83.8 ± 18.9

90.5 ± 32.7

0.144

Operating time (min)

116.1 ± 45.5

113.6 ± 45.8

119.3 ± 45.3

0.479

Intraoperative blood loss (mL)

84.6 ± 11.5

90.2 ± 139

77.2 ± 73.9

0.526

PCPS

15 (11.5%)

8 (10.3%)

7 (12.3%)

0.793

(prophylactic/emergency)

(13/2)

(6/2)

(7/0)

 

Post-balloon dilation

39 (29.8%)

23 (31.1%)

16 (28.1%)

0.709

Intubation time of > 48 h

3 (2.3%)

2 (2.7%)

1 (1.8%)

0.730

Intensive care unit stay (days)

1.9 ± 4.6

1.6 ± 1.9

2.4 ± 6.7

0.328

Pacemaker implantation

10 (7.6%)

3 (4.1%)

7 (12.3%)

0.079

Atrial fibrillation

10 (7.6%)

5 (6.8%)

5 (8.8%)

0.667

Major stroke

2 (1.5%)

2 (2.7%)

0 (0%)

0.211

Acute kidney injury

3 (2.3%)

2 (2.7%)

1 (1.8%)

0.710

Tracheotomy

1 (0.7%)

0 (0%)

1 (1.8%)

0.253

Blood transfusions

64 (49%)

36 (48.7%)

28 (49%)

0.957

Infection

0 (0%)

0 (0%)

0 (0%)

Sepsis

0 (0%)

0 (0%)

0 (0%)

Death

0 (0%)

0 (0%)

0 (0%)

  1. DPC: decrease in platelet count; BEV: balloon-expandable valve; PCPS: percutaneous cardiopulmonary support
  2. Data are presented as mean ± standard deviation or n (%)